Works matching DE "IRBESARTAN"

Results: 210

Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece.

Published in:

European Journal of Health Economics, 2011, v. 12, n. 3, p. 253, doi. 10.1007/s10198-010-0243-5

By:

Maniadakis, Nikos;
Ekman, Mattias;
Fragoulakis, Vasilios;
Papagiannopoulou, Vasiliki;
Yfantopoulos, John

Publication type:

Article

A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 849, doi. 10.1007/s00228-022-03439-3

By:

Hedenmalm, Karin;
Quinten, Chantal;
Kurz, Xavier;
Bradley, Marie;
Lee, Hana;
Eworuke, Efe

Publication type:

Article

Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 8, p. 1021, doi. 10.1007/s00228-018-2477-6

By:

Pei, Qi;
Liu, Jun-Yan;
Yin, Ji-Ye;
Yang, Guo-Ping;
Liu, Shi-Kun;
Zheng, Yi;
Xie, Pan;
Guo, Cheng-Xian;
Luo, Mi;
Zhou, Hong-Hao;
Li, Xi;
Liu, Zhao-Qian

Publication type:

Article

CYP2C93 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 2, p. 149, doi. 10.1007/s00228-011-1098-0

By:

Choi, Chang-Ik;
Kim, Mi-Jeong;
Chung, Eun-Kyung;
Lee, Hye-In;
Jang, Choon-Gon;
Bae, Jung-Woo;
Lee, Seok-Yong

Publication type:

Article

Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria.

Published in:

Amino Acids, 2012, v. 42, n. 5, p. 1627, doi. 10.1007/s00726-011-0857-7

By:

Rabbani, Naila;
Adaikalakoteswari, Antonysunil;
Rossing, Kasper;
Rossing, Peter;
Tarnow, Lise;
Parving, Hans-Henrik;
Thornalley, Paul

Publication type:

Article

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman.

Published in:

Medical Principles & Practice, 2013, v. 22, n. 3, p. 265, doi. 10.1159/000345389

By:

Al Balushi, K.A.;
Habib, J.Q.;
Al-Zakwani, I.

Publication type:

Article

Efficacy and Safety of Incremental Dosing of a New Single-Pill Formulation of Perindopril and Amlodipine in the Management of Hypertension.

Published in:

American Journal of Cardiovascular Drugs, 2019, v. 19, n. 3, p. 313, doi. 10.1007/s40256-018-00314-4

By:

Poulter, Neil R.;
Dolan, Eamon;
Gupta, Ajay K.;
O'Brien, Eoin;
Whitehouse, Andrew;
Sever, Peter S.

Publication type:

Article

Irbesartan/Amlodipine: A Review of its Use in Adult Patients with Essential Hypertension Not Adequately Controlled with Monotherapy.

Published in:

American Journal of Cardiovascular Drugs, 2013, v. 13, n. 2, p. 141, doi. 10.1007/s40256-013-0014-7

By:

Garnock-Jones, Karly

Publication type:

Article

Role of Irbesartan in Prevention of Post-Coronary Artery Bypass Graft Atrial Fibrillation.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 4, p. 277, doi. 10.2165/11587160-000000000-00000

By:

El-Haddad, Mohamed A.;
Zalawadiya, Sandip K.;
Awdallah, Hany;
Sabet, Sameh;
El-Haddad, Haitham A.;
Mostafa, Ashraf;
Rashed, Ahmed;
El-Naggar, Wael;
Farag, Nabil;
Saleb, Mohamed A.;
Jacob, Sony

Publication type:

Article

Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands: A Comparative Analysis Using Clinical Trial and Drug Utilization Data.

Published in:

American Journal of Cardiovascular Drugs, 2010, v. 10, n. 1, p. 49, doi. 10.2165/11319570-000000000-00000

By:

Boersma, Cornelis;
Voors, Adriaan A.;
Visser, Sipke T.;
de Jong-van den Berg, Lolkje T. W.;
Postma, Maarten J.

Publication type:

Article

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study.

Published in:

Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14405

By:

Piazza, M.;
Hanssen, N. M. J.;
Persson, F.;
Scheijen, J. L.;
van de Waarenburg, M. P. H.;
van Greevenbroek, M. M. J.;
Rossing, P.;
Hovind, P.;
Stehouwer, C. D. A.;
Parving, H‐H.;
Schalkwijk, C. G.

Publication type:

Article

Molecular Mobility and Physical Stability of Amorphous Irbesartan.

Published in:

Scientia Pharmaceutica, 2009, v. 77, n. 3, p. 695, doi. 10.3797/scipharm.0806-09

By:

Chawla, Garima;
Bansal, Arvind K.

Publication type:

Article

Bioequivalence study of 300 mg irbesartan film-coated tablets preparations in healthy Thai volunteers.

Published in:

Thai Journal of Pharmaceutical Sciences, 2013, v. 37, n. 4, p. 186

By:

Puranajoti, Porranee;
Werarak, Peerawong;
Intawong, Burapat;
Hongrapipat, Jarunee;
Talubsri, Rungrudee;
Sangsuriyawong, Soravee;
Kuamsuk, Temsiri

Publication type:

Article

AT1-receptor blockade: Protective effects of irbesartan in cardiomyocytes under hypoxic stress.

Published in:

PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0202297

By:

Boccellino, Mariarosaria;
Di Domenico, Marina;
Donniacuo, Maria;
Bitti, Giuseppe;
Gritti, Giulia;
Ambrosio, Pasqualina;
Quagliuolo, Lucio;
Rinaldi, Barbara

Publication type:

Article

Irbesartan restored aquaporin-1 levels via inhibition of NF-kB expression in acute kidney injury model.

Published in:

Nefrologia, 2024, v. 44, n. 4, p. 540, doi. 10.1016/j.nefro.2023.11.005

By:

Candan, Busra;
Ilhan, Ilter;
Sarman, Emine;
Sevimli, Murat

Publication type:

Article

High doses of irbesartan offer long-term kidney protection in cases of established diabetic nephropathy.

Published in:

Nefrologia, 2012, v. 32, n. 2, p. 187, doi. 10.3265/Nefrologia.pre2011.Nov.10962

By:

Ros-Ruiz, Silvia;
Aranda-Lara, Pedro;
Fernández, Juan C.;
Martínez-Esteban, M. Dolores;
Jironda, Cristina;
Hidalgo, Pilar;
Hernández-Marrero, Domingo

Publication type:

Article

Irbesartan did not reduce cardio events in atrial fibrillation patients.

Published in:: Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 83
Publication type:: Article

Drug-drug interaction between danshensu and irbesartan and its potential mechanism.

Published in:

Xenobiotica, 2024, v. 54, n. 4, p. 211, doi. 10.1080/00498254.2024.2338183

By:

Li, Yuexia;
Liu, Liheng

Publication type:

Article

Appropriate nomenclature: angiotensin II receptors.

Published in:

2015

By:

D'Amore, A;
Mitchell, EKL

Publication type:

Letter to the Editor

Rational Design and Characterization of Transdermal Patch of Irbesartan for Hypertension.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2020, v. 54, p. 464, doi. 10.5530/ijper.54.3s.145

By:

Dubey, Roshan Kumar;
Dewangan, Hitesh Kumar

Publication type:

Article

Irbesartan, an angiotensin II type 1 receptor blocker, inhibits colitis-associated tumourigenesis by blocking the MCP-1/CCR2 pathway.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-99412-8

By:

Hachiya, Kensuke;
Masuya, Masahiro;
Kuroda, Naoki;
Yoneda, Misao;
Tsuboi, Junya;
Nagaharu, Keiki;
Nishimura, Komei;
Shiotani, Takuya;
Ohishi, Kohshi;
Tawara, Isao;
Katayama, Naoyuki

Publication type:

Article

Irbesartan protects against aluminium chloride induced amyloidogenesis and cognitive impairment.

Published in:

Journal of Krishna Institute of Medical Sciences (JKIMSU), 2022, v. 11, n. 2, p. 18

By:

Mishra, Sunita;
Prusty, Shakti Ketan;
Sahu, Pratap Kumar;
Das, Debajyoti

Publication type:

Article

Irbesartan Ameliorates Lipid Deposition by Enhancing Autophagy via PKC/AMPK/ULK1 Axis in Free Fatty Acid Induced Hepatocytes.

Published in:

Frontiers in Physiology, 2019, p. N.PAG, doi. 10.3389/fphys.2019.00681

By:

He, Juan;
Ding, Jian;
Lai, Qiuhua;
Wang, Xinke;
Li, Aimin;
Liu, Side

Publication type:

Article

Efficacy and safety of early versus late titration of fixed-dose Irbesartan/hydrochlorothiazide: ACTUAL study.

Published in:: Blood Pressure, 2012, v. 21, n. 1, p. 69, doi. 10.3109/08037051.2012.654697
Publication type:: Article

Candesartan Causes Long-lasting Antagonism of the Angiotensin II Receptor-mediated Contractile Effects in Isolated Vascular Preparations: a Comparison with Irbesartan, Losartan and its Active Metabolite (EXP-3174).

Published in:

Blood Pressure, 2000, v. 9, p. 52, doi. 10.1080/080370500439434

By:

ABRAHAMSSON,, T.;
KARP,, L.;
BRANDT-ELIASSON,, U.;
MORSING,, P.;
RENBERG,, L.;
SJÖQUIST, P.-O.

Publication type:

Article

Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Published in:

PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0126882

By:

Peters, Christian Daugaard;
Kjaergaard, Krista Dybtved;
Jensen, Jens Dam;
Christensen, Kent Lodberg;
Strandhave, Charlotte;
Tietze, Ida Noerager;
Novosel, Marija Kristina;
Bibby, Bo Martin;
Jespersen, Bente

Publication type:

Article

Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE−/− Mice: Molecular Imaging with 14C-FDG and 99mTc-Annexin A5.

Published in:

PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089338

By:

Zhao, Yan;
Watanabe, Ayahisa;
Zhao, Songji;
Kobayashi, Tatsuo;
Fukao, Keita;
Tanaka, Yoshikazu;
Nakano, Toru;
Yoshida, Tetsuya;
Takemoto, Hiroshi;
Tamaki, Nagara;
Kuge, Yuji

Publication type:

Article

Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan.

Published in:

Vascular Health & Risk Management, 2013, v. 9, p. 575, doi. 10.2147/VHRM.S50831

By:

Gialama, Fotini;
Maniadakis, Nikos

Publication type:

Article

P167 Simvastatin & irbesartan suppresses inflammatory responses, chemokine expressions and apoptosis induced by myocardial ischemia/reperfusion in male rats.

Published in:

Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S29, doi. 10.1093/cvr/cvu082.104

By:

Hadi, N R;
Alamran, F G;
Yousif, M G;
Mohammad, B I;
Zamil, S T

Publication type:

Article

Acute neck swelling: A diagnostic dilemma in a regional hospital.

Published in:

2010

By:

Pedersen, Alan

Publication type:

Case Study

Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial.

Published in:: Current Medical Literature: Diabetes, 2011, v. 28, n. 4, p. 154
Publication type:: Article

Management - Complications and Comorbidities.

Published in:: Current Medical Literature: Diabetes, 2010, v. 27, n. 1, p. 31
Publication type:: Article

Management - Complications and Comorbidities.

Published in:: Current Medical Literature: Diabetes, 2009, v. 26, n. 4, p. 108
Publication type:: Article

Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.

Published in:

Heart & Vessels, 2016, v. 31, n. 12, p. 2053, doi. 10.1007/s00380-016-0853-7

By:

Kataoka, Naoya;
Nishida, Kunihiro;
Kinoshita, Koshi;
Sakamoto, Tamotsu;
Nakatani, Yosuke;
Tsujino, Yasushi;
Mizumaki, Koichi;
Inoue, Hiroshi;
Kinugawa, Koichiro

Publication type:

Article

Combined effects of irbesartan and carvedilol on expression of tissue factor and tissue factor pathway inhibitor in rats after myocardial infarction.

Published in:

Heart & Vessels, 2011, v. 26, n. 6, p. 646, doi. 10.1007/s00380-010-0106-0

By:

Yu, Junmin;
Zhao, Jiyi;
Liu, Wei;
Ge, Zhenzhong;
Du, Yongli

Publication type:

Article

Experimental and DFT characterization, antioxidant and anticancer activities of a Cu(II)-irbesartan complex: structure-antihypertensive activity relationships in Cu(II)-sartan complexes.

Published in:

Journal of Biological Inorganic Chemistry (JBIC), 2016, v. 21, n. 7, p. 851, doi. 10.1007/s00775-016-1384-5

By:

Islas, María;
Luengo, Alicia;
Franca, Carlos;
Merino, Mercedes;
Calleros, Laura;
Rodriguez-Puyol, Manuel;
Lezama, Luis;
Ferrer, Evelina;
Williams, Patricia

Publication type:

Article

The Effect of Combined Antihypertensive Treatment (Felodipine with Either Irbesartan or Metoprolol) on Erectile Function: A Randomized Controlled Trial.

Published in:

Cardiology, 2013, v. 125, n. 4, p. 235, doi. 10.1159/000350955

By:

Yang, Longquan;
Yu, Jing;
Ma, Ruixin;
Zhao, Feng;
Lin, Xin;
Liu, Peijun;
Hu, Hao;
Bai, Feng

Publication type:

Article

Irbesartan Attenuates Atherosclerosis in Watanabe Heritable Hyperlipidemic Rabbits: Noninvasive Imaging of Inflammation by 18F-Fluorodeoxyglucose Positron Emission Tomography.

Published in:

Molecular Imaging, 2015, v. 14, p. 1, doi. 10.2310/7290.2015.00004

By:

Yan Zhao;
Keita Fukao;
Songji Zhao;
Ayahisa Watanabe;
Tadateru Hamada;
Kazuaki Yamasaki;
Yoichi Shimizu;
Naoki Kubo;
Naoyuki Ukon;
Toru Nakano;
Nagara Tamaki;
Yuji Kuge

Publication type:

Article

SPECTROPHOTOMETRIC DETERMINATION OF ACTIVE COMPOUNDS IN AN ANTIHYPERTENSIVE FORMULATION BY HAAR-CWT METHOD.

Published in:

Journal of Faculty of Pharmacy of Ankara University / Ankara Üniversitesi Eczacilik Fakültesi Dergisi, 2021, v. 45, n. 3, p. 535, doi. 10.33483/jfpau.986786

By:

ÜSTÜNDAĞ, Özgür;
DİNÇ, Erdal

Publication type:

Article

Comparison of clinical efficacy of metoprolol combined with irbesartan and hydrochlorothiazide and non-invasive ventilator in the emergency treatment of patients with severe heart failure.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 5059, doi. 10.3892/etm.2018.6828

By:

Zhang, Fangxia;
Zhou, Guoxia;
Guo, Lisha;
Lu, Fei;
Zhou, Guojun

Publication type:

Article

Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease.

Published in:

Experimental & Therapeutic Medicine, 2018, v. 16, n. 5, p. 4119, doi. 10.3892/etm.2018.6669

By:

Li, Tao;
Yao, Weina

Publication type:

Article

Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan.

Published in:

Global Cardiology Science & Practice, 2020, v. 2020, n. 2, p. 1, doi. 10.21542/gcsp.2020.25

By:

Ray, Avik;
Atal, Shubham;
Sadasivam, Balakrishnan

Publication type:

Article

Irbesartan promotes erection recovery after nerve-sparing radical retropubic prostatectomy: a retrospective long-term analysis.

Published in:

BJU International, 2012, v. 110, n. 11, p. 1782, doi. 10.1111/j.1464-410X.2012.11098.x

By:

Segal, Robert L.;
Bivalacqua, Trinity J.;
Burnett, Arthur L.

Publication type:

Article

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes.

Published in:

Clinical Pharmacology, 2014, v. 6, p. 79, doi. 10.2147/CPAA.S61462

By:

Makiko Nakamura;
Nobuo Sasai;
Ichiro Hisatome;
Kimiyoshi Ichida

Publication type:

Article

Pharmacokinetic interaction between irbesartan and Orthosiphon stamineus extract in rat plasma.

Published in:

Asian Journal of Pharmaceutical Sciences, 2016, v. 11, n. 1, p. 70, doi. 10.1016/j.ajps.2015.10.055

By:

Meilis, Nur;
Harahap, Yahdiana;
Saputri, Fadlina Chany;
Munim, Abdul;
Setiabudy, Rianto

Publication type:

Article

Quantitative estimation of irbesartan in two different matrices and its application to human and dog bioavailability studies using LC-MS/MS.

Published in:

Asian Journal of Pharmaceutical Sciences, 2013, v. 8, n. 6, p. 346, doi. 10.1016/j.ajps.2013.11.005

By:

Tiwari, Hari Krishan;
Monif, Tausif;
Verma, Priya Ranjan Prasad;
Reyar, Simrit;
Khuroo, Arshad Hussain;
Mishra, Sanjeev

Publication type:

Article

Irbesartan Fails to Prevent Most Vascular Events in Patients with AF.

Published in:: MD Conference Express, 2009, p. 12, doi. 10.1177/155989770904005
Publication type:: Article

Rapid Stability-indicating RRLC Method for Simultaneous Estimation of Irbesartan and its Related Impurities.

Published in:

Indian Journal of Pharmaceutical Sciences, 2016, v. 78, n. 2, p. 252, doi. 10.4172/pharmaceutical-sciences.1000110

By:

RAO, K. TIRUMALA;
RAO, L. VAIKUNTA;
KANDEPI, V. V. KRISHNA MOHAN

Publication type:

Article

Systematic Approach for Trace Level Quantification of 2-N-butyl-4-spirocyclopentane-2-imidazole-5-one Genotoxic Impurity in Irbesartan Using LC-MS/MS.

Published in:

Indian Journal of Pharmaceutical Sciences, 2013, v. 75, n. 5, p. 501

By:

BHASKAR REDDY, A. VIJAYA;
VENUGOPAL, N.;
MADHAVI, G.;
MADHAVI, V.;
GANGADHARA REDDY, K.

Publication type:

Article

Top 10 drugs 2023-24.

Published in:: Australian Prescriber, 2024, v. 47, n. 6, p. 194, doi. 10.18773/austprescr.2024.048
Publication type:: Article